Literature DB >> 29285161

Hemorrhagic pleural effusion related to acquired coagulation factor VIII deficiency: A case report.

Yu-Ping Liu1, Xiang-Hua Lin2, Xue-Ke Wang3, Shang-Zhi Yang4, Chang-Qing Fan5.   

Abstract

A patient with acquired hemophilia A (AHA) with hemorrhagic pericardial effusions was admitted to Xiamen Chang Gung Hospital (Xiamen, China) in August 2015. The patient had been experiencing progressive dyspnea for 1 week. Bloody effusion (~6.3 l) was drained from the membrane surrounding the heart over a period of 20 days. Biochemical, cytological and radiological examinations were unable to elucidate the reason for the effusion. Coincidentally, it was discovered that activated partial thromboplastin time prolongation could not be corrected by plasma mixing. Furthermore, immunologic and functional assays identified that the patient had factor VIII-deficient plasma. Finally, the coagulopathy was treated by infusion of cryoagglutinin and steroids to eradicate the coagulation inhibitor. The production of cardiac bloody effusions did not recur. Notably, the patient was diagnosed with AHA accompanied by the rare complication of pericardial effusions. The present case was the first to report AHA with the complication of pericardial effusions.

Entities:  

Keywords:  acquired factor VIII deficiency; acquired hemophilia A; cryoagglutinin; hemorrhagic pericardial effusions; steroids

Year:  2017        PMID: 29285161      PMCID: PMC5740789          DOI: 10.3892/etm.2017.5339

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  7 in total

1.  Bloody pericardial effusion in patients with cardiac tamponade: is the cause cancerous, tuberculous, or iatrogenic in the 1990s?

Authors:  S Atar; J Chiu; J S Forrester; R J Siegel
Journal:  Chest       Date:  1999-12       Impact factor: 9.410

2.  Diagnosis and treatment of congenital and acquired hemophilia.

Authors:  Satoshi Higasa
Journal:  Rinsho Ketsueki       Date:  2017

Review 3.  Acquired factor VIII inhibitors: pathophysiology and treatment.

Authors:  Alice D Ma; Daniel Carrizosa
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

Review 4.  Advances in the understanding of acquired haemophilia A: implications for clinical practice.

Authors:  Peter W Collins; Charles L Percy
Journal:  Br J Haematol       Date:  2009-10-07       Impact factor: 6.998

Review 5.  Factor VIII structure and function.

Authors:  Philip J Fay
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

Review 6.  Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.

Authors:  Davide Matino; Michael Makris; Kerry Dwan; Roberto D'Amico; Alfonso Iorio
Journal:  Cochrane Database Syst Rev       Date:  2015-12-16

7.  International recommendations on the diagnosis and treatment of patients with acquired hemophilia A.

Authors:  Angela Huth-Kühne; Francesco Baudo; Peter Collins; Jørgen Ingerslev; Craig M Kessler; Hervé Lévesque; Maria Eva Mingot Castellano; Midori Shima; Jean St-Louis
Journal:  Haematologica       Date:  2009-04       Impact factor: 9.941

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.